The University of Chicago Header Logo

Connection

Lilly Immergluck to Randomized Controlled Trials as Topic

Back to Details
This is a "connection" page, showing publications Lilly Immergluck has written about Randomized Controlled Trials as Topic.
Lilly Immergluck
Connection Strength
0.176
Randomized Controlled Trials as Topic
  1. Evaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial Data: A Secondary Cross-Protocol Analysis of 5 Randomized Clinical Trials. JAMA Netw Open. 2025 May 01; 8(5):e2512763.
    View in: PubMed
    Score: 0.176
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.